Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00B5SGVL29 ORD 0.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.00 0.95 1.05 1.00 1.00 1.00 678,515 07:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 11.6 -8.9 -0.7 - 12

Tissue Regenix Share Discussion Threads

Showing 12576 to 12593 of 12600 messages
Chat Pages: 504  503  502  501  500  499  498  497  496  495  494  493  Older
DateSubjectAuthorDiscuss
13/2/2020
09:01
ORM AGM today, buyers piling in
jibba jabber
11/2/2020
19:02
A rights issue is more costly than a placing - they should do a placing and open offer
nxc
11/2/2020
16:42
If all goes well with all that's been mentioned in rns to date (expansion, shift increase, more production sales) profit increase will solve everything. :)
monster500
11/2/2020
16:02
ETX today illustrative. Sometimes a capital raise can be good. TRX need to sort out their balance sheet. The risk premia attached to the stock due to financing concern is larger than that of equity dilution. A Rights Issue would be the best way to proceed. Get a Rights Issue away at 0.5p or 1p and the stock will go up to 1p to 2p giving investors immediate 50-100% uplift IMO
the stigologist
11/2/2020
15:47
Why would there be a fundraise ? They have 10.5m they can draw down through Midcap , the report was for restructuring, no placing coming here they have plenty of partners who would be more than happy to help
smokingjoe
11/2/2020
14:06
UPDATED broker note --- New broker note http://bit.ly/2RCVKIH
sharetimebuy
11/2/2020
13:54
Hardman's report was for me much better than is normal and good to see it clear that TRX need the equity injection which Hardman have modelled at £9m to get out of what Hardman describe as the catch 22 situation of financing the expansion in San Antonio that TRX need to take the business forward. Given the increase in long term debt as well as EBIT losses forecast in 2021, this £9m figure does not seem unreasonable. I have not kicked the tyres of their report too hard-but not sure why their cash flow forecast has £3.6m interest expense in 2021. As the Hardman report makes clear they have a week shareholder base-and of course no FD with City links. On the basis that a new fund raise would be at 1p per share we are looking at 900m shares being issued compared to their current 1172m shares in issue-and we are forgetting about the actual costs of the share increase. I am not sure what is to be gained by waiting-although on the basis that John Glen the NED may have more time on his hands as the CSRT takeover is finalized ,he can spend some time sorting this. I bought in too early 4 weeks ago and well done to those who sold at 1.7p a couple of weeks back. Views welcome.
cerrito
11/2/2020
12:32
Some nice buy trades this morning. Looking good for the afternoon. :)
monster500
11/2/2020
09:02
Yes, never did get that tr-1 did we?
jibba jabber
10/2/2020
14:50
Hardly crazy.. a million of these is only £10k. PIs moving money about probably. Progress on the financing will see us fly.
holdingtight
10/2/2020
13:25
The volume continues to be crazy here. Woodie got to be gone soon.
theapplefreak
06/2/2020
09:17
https://www.hardmanandco.com/research/corporate-research/restructured-to-satisfy-product-demand/
grahamburn
06/2/2020
08:06
"The shares are trading at a discount of 87% to the £95.8m (8.2p per share) that has been invested in the company to date."
the stigologist
05/2/2020
00:49
In the risers, biotech group Tissue Regenix surged 17.5 per cent, or 0.17p, to 1.18p, following restoration of its critical IT systems after a cybersecurity breach last week. htTps://www.thisismoney.co.uk/money/markets/article-7967291/MARKET-REPORT-bad-news-post-Royal-Mail-investors.html
the stigologist
04/2/2020
14:13
Looking good some really big buys today:)
monster500
04/2/2020
13:06
That's excellent news, at least it back!
amrishbhim
04/2/2020
13:05
He certainly his confident, I think we should see the year high back again. Company good in hand
amrishbhim
04/2/2020
13:04
That's certainly not true, u can do both
amrishbhim
Chat Pages: 504  503  502  501  500  499  498  497  496  495  494  493  Older
Your Recent History
LSE
TRX
Tissue Reg..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200220 08:44:59